What is the mechanism by which bleomycin damages DNA?

What is the mechanism by which bleomycin damages DNA?

• A. By directly methylation of the DNA
• B. By intercalating and generating free radicals
• C. By causing cross-linking of DNA strands
• D. By inhibiting RNA synthesis

Answer: (B)

Bleomycin damages DNA primarily through its ability to intercalate into DNA and generate free radicals. Once bleomycin binds to the DNA, it forms a complex that facilitates the generation of reactive oxygen species (ROS). These ROS can then lead to strand breaks in the DNA helix, resulting in significant damage. The process begins with bleomycin undergoing oxidation and transitioning into an active form that can interact with molecular oxygen, a reaction that produces free radicals. It is these free radicals that mediate the cleavage of the DNA strands. The resultant breaks can hinder DNA replication and transcription, leading to cell death, which is particularly relevant in the treatment of cancer. This method of action distinguishes bleomycin from other types of chemotherapeutic agents that may function by different mechanisms, such as directly methylating DNA, creating cross-links within the DNA strands, or inhibiting RNA synthesis. Each of those processes involves distinct biochemical pathways and effects on cellular processes, which do not accurately describe how bleomycin operates.

Bleomycin damages DNA primarily through its ability to intercalate into DNA and generate free radicals. Once bleomycin binds to the DNA, it forms a complex that facilitates the generation of reactive oxygen species (ROS). These ROS can then lead to strand breaks in the DNA helix, resulting in significant damage.

The process begins with bleomycin undergoing oxidation and transitioning into an active form that can interact with molecular oxygen, a reaction that produces free radicals. It is these free radicals that mediate the cleavage of the DNA strands. The resultant breaks can hinder DNA replication and transcription, leading to cell death, which is particularly relevant in the treatment of cancer.

This method of action distinguishes bleomycin from other types of chemotherapeutic agents that may function by different mechanisms, such as directly methylating DNA, creating cross-links within the DNA strands, or inhibiting RNA synthesis. Each of those processes involves distinct biochemical pathways and effects on cellular processes, which do not accurately describe how bleomycin operates.